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CASE REPORT
Transcatheter Leadless Cardiac Pacing with Limited
Venous Access
CHU-PAK LAU, M.D., F.H.R.S.*,† and KATHY LAI-FUN LEE, M.B.B.S., F.A.C.C.*Q1
From the *Cardiology Division, Department of Medicine, Queen Mary Hospital, the University of Hong Kong, Hong
Kong SAR, China; and †Research Center of Heart, Brain, Hormone and Healthy Ageing, Li Ka Shing Faculty of
Medicine, the University of Hong Kong, Hong Kong SAR, China
Entirely leadless cardiac pacemakers that are delivered transvenously required the use of large diameter
delivery sheath and femoral venous approach. The complexity of external femoral and iliac venous
anatomy may limit their implantation. We describe a patient without subclavian venous access and a
conventional pacemaker with a failed right ventricular lead, who had difficult iliac venous anatomy that
was also compressed by an external endovascular abdominal aortic stent. Successful leadless pacing using
a MicraTM (Medtronic Inc) was accomplished with a strong support wire, hydrophilic delivery sheath and
guided by venography. (PACE 2016; 00:1–4)
leadless cardiac pacing, heart block, aortic stent graft
Introduction
Transcatheter deployed entirely leadless car-
diac pacemaker (LPM) avoids the complications
associated with pacing leads and pacemaker
pockets.1,2 Current LPMs require large diameter
sheaths that are introduced through the femoral
veins. There is limited information on the
implantation of LPM in patients with limited or
difficult venous anatomy.
Patient and Method
An 81-year-old woman with atrial fibrillation
and complete heart block had a DDDR pacemaker
implanted over her left infraclavicular area
10 years ago. She had chronic renal failure forQ2
7 years, and hemodialysis (HD) using arteriove-
nous fistulae on either arm, right subclavian
and right internal jugular veins failed because of
tortuosity and repeated infection. She was finally
dialysed from a right femoral HD catheter. In 2010,
she developed a leaking infrarenal abdominal
aortic aneurysm and underwent an emergency
endovascular repair with aortic stent graft (EVAR:
Enduran 26/13/145 + 16/24/80R and 16/24/120L)
in the lower abdominal aorta straddling into
the two common iliac arteries. At the time of
pacemaker replacement in 2012, the ventricular
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lead had a threshold of 4 V at 0.4 ms. An attempt
to introduce a new ventricular lead failed and a
Boston Scientific AltruaTM was implanted using
the original high threshold ventricular lead. The
device was programmed at 6.5 mV at 0.9 ms
and its battery became depleted in 2015. Lead
extraction or an epicardial lead placement was
offered but the patient declined both because of
risk. A decision was made to use an LPM for
pacemaker replacement.
After creation of a subcutaneous purse string
suture in the left femoral venous site, the common
femoral vein was punctured and a stiff support
wire was inserted and placed at the level of the
right atrium. The support wire had a tortuous
course in the left common iliac vein (LCIV)
and the Medtronic 27F hydrophilic sheath and
dilator failed to track across (Fig. 1A). A hand
injection cine-angiogramwas then performedwith
multipurpose catheter tracked over this wire.
The injection showed that the whole LCIV was
severely compressed by the right and left iliac
extensions of EVAR, and that the multipurpose
catheter was in the lower tortuous patent channel
(Fig. 1B). The wire was, therefore, repositioned to
the straighter patent upper channel. The sheath
and dilator was then tracked over the wire but
was caught between the left and right common
iliac extensions of the EVAR stent in front, and the
pelvic bone behind. Using a series of progressively
larger dilators, the venous passage was dilated up
to 27F size. With gentle but sustained pushing
and pulling on the support wire (push and pull
technique), the venous sheath and dilator finally
achieved a right atrial position, and crossed the
tricuspid valve without problem or interference
©2016 Wiley Periodicals, Inc.
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Figure 1. (A) Cine-angiogram in the anteroposterior view of the pelvis showing the placement of a support wire
from the left femoral vein, through the left common iliac vein (LCIV) into the inferior vena cava. Shown also are the
endovascular aortic repair stent graft (EVAR) with its right (R) and left iliac (L) extensions. The MicraTM deployment
sheath could not track over the wire because of venous tortuosity. (B) Hand-injection cine-angiogram in the same
position using a 5F multipurpose (MP) catheter in the LCIV tracked over the support wire. The LCIV was severely
compressed by the iliac limbs of the EVAR. The MP catheter was in the tortuous lower patent channel of the LCIV,
which was pacified with this injection, with its entry into the right common iliac vein (RCIV) and reflux of contrast
to the inferior vena cava (IVC). An upper channel of the LCIV has a straighter course (arrows), and the MicraTM
deployment sheath was successfully tracked over the support wire subsequently placed in this channel.
by the right ventricular lead. AMedtronicMicraTM
TCPwas then deployed over the sheath in the right
ventricle. Again, hand injection from the sheath
identified it to be above the apex to minimize
the risk of ventricular perforation. There was
no mechanical interference with the implanted
right ventricular lead. A threshold of 0.88 V at
0.24 ms was achieved. The device was then de-
ployed, sheath removed, and hemostasis achieved
with the subcutaneous purse string suture. The
old pacemaker was programmed to the minimum
lower rate (30 beats/min) and output. The patient
made an uneventful recovery, and there was
no groin access complication. When seen at
6 weeks and 3 months, the MicraTM TCP had
a ventricular threshold of 0.63 V and 0.5 V at
0.24 ms, respectively. There was satisfactory rate
adaptation in the VVIR mode. There was no
electrical interference with the implanted device
or pacemaker syndrome.
Discussion
Current LPMs are relatively large in diameter,
and require large diameter delivery sheaths for
transcatheter deployment (21F in St. Jude Medical
LCPTM, and 27F in Medtronic MicraTM TCP).
These large sheaths are delivered from a femoral
venous approach. Because the right common iliac
artery crosses in front of the LCIV, the vein is
naturally compressed and in some patients venous
drainage of the left leg may be compromised
(May-Thurner syndrome).3 In this case, the venous
passage for the delivery sheath is compressed even
further by the rigid EVAR metal stent in both
the left and right common iliac arteries. A right
femoral venous approach should be easier as the
vein is not compressed in front, but is not possible
in this patient due to an indwelling HD catheter.
By choosing the less obstructed upper venous
channel in the LCIV, and using sequentially
upsized venous dilators, a stiff support wire, and
push and pull technique, the slippery hydrophilic
sheath and dilator was successfully passed across
the compressed LCIV into the superior vena cava.
We did not find difficulty in physical
interference of the delivery catheter and the
indwelling ventricular lead across the tricuspid
valve. Passage across the tricuspid valve is
facilitated by deflectable sheath. With careful
positioning and contrast injection, there is no
physical interference between the implanted right
ventricular lead or the LPM. In a cadaveric study,4
up to 3 MicraTM TCP could be implanted in
the right ventricle without physical interference.
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Figure 2. Chest and upper abdomen x-ray showing four implanted devices in the patient.
EVAR = endovascular aortic repair stent graft; HD = hemodialysis catheter; LPM = entirely
leadless cardiac pacemaker; PM = conventional permanent pacemaker. Q3
There was no physical or electrical interference in
our patient both during supine or standing when
she was ambulant. An implanted pacemaker is
an exclusion criteria in the published MicraTM
TCP trial.2 However, this patient demonstrates
that LPM may avoid multiple ventricular leads
across the tricuspid valve in patients whose
right ventricular lead has failed and who are
not candidates for lead extraction. Upper limb
venography may still review patent subclavian
veins and enable a repeat transvenous pacing.
However, our patient, with her multiple venous
failureswas reluctant to any further approach from
the upper chest. Indeed, LPM has been reported
as an alternative to conventional pacing in a
patient with recurrent pocket infection of both
sides of the chest, using the St. Jude Medical
LCPTM LPM.5 In another case, MicraTM TCP was
used in a patient with persistent left superior vena
cava and right subclavian vein that drained to the
abnormal superior vena cava in whom the pacing
system was infected.6 Our patient with multiple
comorbidities and requiring anticoagulation made
leadless pacing a good alternative.7
Conclusion
The case exemplifies the following. (1)
Implantation of LPM is an alternative in patients
who do not have subclavian venous access for per-
manent VVI pacemaker. (2) Contrast venography is
useful to identify the best possible venous passage
for the LPM, and for its positioning in the right
ventricle. (3) In patients with EVAR, passage of
large bore catheters required for deployment of
LPM may be difficult but achievable, although
downsizing of LPM and delivery sheath and
catheters will be useful, and (4) LPM is an option
to avoid multiple right ventricular leads across the
tricuspid valve in case of right ventricular lead
failure.
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